News

The proof-of-concept study will randomize around 375 fibromyalgia patients with TD-9855 or placebo, once a day for nine weeks, and evaluate the safety and efficacy of two TD-9855

The updated prescribing information for Faslodex US contains results and a Kaplan-Meier plot of the final overall survival (OS) analysis from CONFIRM (COmparisoN of FASLODEX In Recurrent or

The new prefilters have combined performance polyethersulfone (PES) membranes and nanofleece technology, used for the first time in liquid prefiltration applications in biopharmaceutical manufacturing. The nanofleece technology has

The regulatory affairs processes include product registration tracking, commitment tracking and other functions required to meet global regulatory directives. As a prescription provider of ophthalmic pharmaceuticals, Santen tracks

As a part of the contract, Boehringer will offer cell line development along with high expression BI-HEX system, full process and method development and scale-up for APX005, an

Candesartan Cilexetil and Hydrochlorothiazide Tablets in 16/12.5mg, 32/12.5mg and 32/25mg strenghts, for which the company began shipment, are equivalent to AstraZeneca’s Atacand HCT medication. The fixed dose drug

The company’s scientists will use D360 to produce integrated project data views and to mine structure activity relationships by using data from their existing chemical registration and biological

Supplied from January 2013, revised formulation is indicated for acute lymphoblastic leukaemia and is free from artificial colours, artificial flavours and sugar. According to the company, the medication

Rayos, which is now available to the US physicians, is used to treat rheumatoid arthritis (RA), polymyalgia rheumatica (PMR), psoriatic arthritis (PsA), ankylosing spondylitis (AS), asthma and chronic